Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olfactory and Neurosensory Rehabilitation in COVID-19-Related Olfactory Dysfunction
NCT04900415Phase 2Unknown
- Start
- Jul 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vitamin a in Olfactory dysfunction (3 arms). Primary endpoints: Subjective olfactory assessment at 4 weeks, Butanol threshold test at 4 weeks and 1 more. Status: unknown.
02
Drugs
vitamin a
03
Conditions
Olfactory dysfunction
Beyond the preview
Go deeper on NCT04900415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04900415.